Morgan Stanley Maintains Equal-Weight on Pinterest, Lowers Price Target to $18
Morgan Stanley analyst Brian Nowak maintains Pinterest (NYSE:PINS) with a Equal-Weight and lowers the price target from $21 to $18.
Why Bank Stocks Traded Sharply Higher; Here’s 65 Biggest Movers From Friday
Gainers
United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Here’s Why Pinterest Stock Is Popping Off Today
Pinterest Inc (NYSE: PINS) shares are trading higher by 16.94% to $20.60 Friday morning. The stock is trading higher following a WSJ report suggesting Elliott Management has been in discussions with the company.
What Happened?
Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday’s Pre-Market Session
Gainers
United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
Citigroup, Pinterest And 3 Stocks To Watch Heading Into Friday
With the US stock futures trading slightly higher this morning on Tuesday ahead of earnings reports from big banks, some of the stocks that may grab investor focus today are as follows:
Why Pinterest Stock Is Skyrocketing During Thursday’s After-Hours Session
Pinterest Inc (NYSE: PINS) shares are trading higher by 19% to $20.90 during Thursday's after-hours session. The sharp rise comes following a WSJ report suggesting Elliott Management has been in discussions with the company.
What Happened?
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Gainers
Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Why These Casino Stocks Are Moving Lower, Here’s 45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.